Skip to main navigation
Skip to search
Skip to main content
Luxembourg Institute of Health Home
Search content at Luxembourg Institute of Health
Home
Profiles
Research units
Research output
Projects
Equipment
Datasets
Innovation in oncology clinical trial design
Cancer Drug Development Forum
Research output
:
Contribution to journal
›
Review article
›
peer-review
57
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Innovation in oncology clinical trial design'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Oncology
100%
Clinical Trial Design
100%
Malignant Neoplasm
66%
Medicine
33%
Cancer Pathobiology
33%
Clinical Study
33%
Decision Making
33%
Awareness
33%
Patient Population
33%
Tumor Histology
33%
Phase II Trials
33%
Phase III Trials
33%
Keyphrases
Oncology Clinical Trials
100%
Innovative Trial Design
66%
Cancer Population
33%
Early Selection
33%
National Agency
33%
Understanding of Cancer
33%
Risk-benefit Analysis
33%
Drug Approval
33%
Oncology Drug Development
33%
Success Probability
33%
Marketing Approval
33%
Small Cancer
33%
Operational Efficiency
33%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial Design
100%
Malignant Neoplasm
66%
Clinical Study
33%
Drug Approval
33%
Cancer Drug Development
33%
Phase II Trials
33%
Neoplasm
33%
Phase III Trials
33%